National Review: As Predicted, Patients Are Paying the Price for the Inflation Reduction Act’s Drug Reform

It has been about four months since President Biden signed the Inflation Reduction Act (IRA) and, already, the law’s drug-pricing rules have dealt a major blow to medical innovation… Read more.

Previous
Previous

SFS New Year’s Resolutions

Next
Next

STAT Newsletter: GOP political vet founds new anti-IRA patient group